Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Athersys Inc (NASDAQ:ATHX)

2.28
Delayed Data
As of May 24
 +0.03 / +1.33%
Today’s Change
0.94
Today|||52-Week Range
2.90
+121.36%
Year-to-Date
3 Stocks That Have Doubled in 2016 Alone
May 12 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close2.25
Today’s open2.28
Day’s range2.22 - 2.30
Volume223,952
Average volume (3 months)864,337
Market cap$189.8M
Dividend yield--
Data as of 05/24/2016

Growth & Valuation

Earnings growth (last year)+35.48%
Earnings growth (this year)-35.00%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+636.17%
P/E ratio236.5
Price/Sales7.14
Price/Book9.55

Competitors

 Today’s
change
Today’s
% change
--Bone Biologics Corp0.000.00%
ZFGNZafgen Inc+0.23+3.35%
CCXIChemoCentryx Inc0.000.00%
IDRAIdera Pharmaceutical...+0.07+4.58%
Data as of 05/24/2016

Financials

Next reporting dateAugust 8, 2016
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$11.9M
Annual profit (last year)-$16.4M
Net profit margin-137.45%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Gil van Bokkelen
President, Chief Operating Officer &
Secretary
William B. J. Lehmann
Corporate headquarters
Cleveland, Ohio

Forecasts

Partner Offers

Search for Jobs